期刊文献+

维生素D及其代谢通路基因多态性与妊娠期高血压疾病相关性研究进展 被引量:3

The Correlation Between Vitamin D and Its Metabolic Pathway Gene Polymorphism and Hypertensive Disorder of Pregnancy
下载PDF
导出
摘要 妊娠期高血压疾病是妊娠与高血压并存的一组疾病,是全球孕产妇和围产儿死亡的主要原因之一,其发病机制尚未完全了解,存在多因素、多机制和多通路发病综合征性质,并受遗传和环境等多重因素影响。维生素D生理作用广泛,对人体健康作用显著。近年来,一些研究发现血清维生素D参与妊娠期高血压疾病的发生和发展,其血清水平经多项研究已证实受其代谢通路基因多态性影响。现分析总结维生素D及其代谢通路基因多态性与妊娠期高血压疾病的相关性,为临床医师采取适当有效的干预措施提供更多的理论依据。 Hypertensive disorder of pregnancy(HDP)refers to a group of diseases,in which pregnancy coexists with hypertension.It is one of the major causes of maternal and perinatal mortality worldwide.The pathophysiology of HDP has not been completely clarified.There are multiple factors,multiple mechanisms and multiple pathways in the nature of the syndrome,which are affected by multiple factors such as heredity and environment.Vitamin D has a wide range of physiological effects and plays a significant role in maintaining human health.In recent years,some studies have found that serum vitamin D is involved in the occurrence and development of HDP,and its serum level has been confirmed by multiple studies to be affected by its metabolic gene polymorphism.This article analyzes and summarizes the correlation between vitamin D and its metabolic pathway gene polymorphism and HDP,so as to provide more theoretical basis for clinicians to take appropriate and effective intervention measures.
作者 曾庆媛 文舒 吕瑜玫 王明义 ZENG Qingyuan;WEN Shu;LYU Yumei;WANG Mingyi(Department of Gynecology and Obstetrics,General Hospital of Western Theater Command of Chinese People’s Liberation Army,Chengdu 610083,Sichuan,China)
出处 《心血管病学进展》 CAS 2022年第11期1033-1037,共5页 Advances in Cardiovascular Diseases
关键词 妊娠期高血压疾病 维生素D 代谢通路基因 基因多态性 Hypertensive disorder of pregnancy Vitamin D Metabolic pathway gene Gene polymorphism
  • 相关文献

参考文献6

二级参考文献86

  • 1胡峦,李艳,刘国栋,李镇武.PCOS患者Vit D水平及其受体基因Taq Ⅰ rs731236T/C位点多态性与Vit D、TGF-β1水平之间的相关性[J].中国优生与遗传杂志,2020(9):1052-1054. 被引量:1
  • 2乐杰.妇产科学[M].7版.北京:人民卫生出版社,2010:366. 被引量:231
  • 3Roberts JM, Cooper OW. Pathogenesis and genetics of pre?eciampsia[J]. Lancet, 2001, 357(9249):53-56. 被引量:1
  • 4Grill S, Rusterholz C, Zanetti-Oiillenbach R, et al. Potential markers of preeclampsia--a review[J]. Reprod Bioi Endocrinol, 2009,7:70. 被引量:1
  • 5Ma R, Gu Y, Zhao S, et al. Expressions of vitamin 0 metabolic components VOBP, CYP2RI, CYP27BI, CYP24AI, and VOR in placentas from normal and preeclamptic pregnancies[J]. Am J Physiol Endocrinol Metab, 2012, 303(7):E928-935. 被引量:1
  • 6Brodowski L, Burlakov J, Myerski AC, et al. Vitamin 0 prevents endothelial progenitor cell dysfunction induced by sera from women with preeclampsia or conditioned media from hypoxic placenta[J]. PLoS One, 2014, 9(6):e98527. 被引量:1
  • 7von Versen-Hiiynck F, Brodowski L, Oechend R, et al. Vitamin D antagonizes negative effects of preeclampsia on fetal endothelial colony forming cell number and function[J]. PLoS One, 2014, 9(6):e98990. 被引量:1
  • 8Abedi P, Mohaghegh Z, Afshary P, et al. Tbe relationship of serum vitamin 0 with pre-eclampsia in the Iranian women[J]. Matern Child Nutr, 2014,10(2):206-212. 被引量:1
  • 9Bodnar LM, Catov JM, Simhan HN, et al. Maternal vitamin D deficiency increases the risk of preeclampsia[J]. J Clin Endocrinol Metab, 2007,92(9):3517-3522. 被引量:1
  • 10Mendel CM. The free hormone hypothesis: a physiologically based mathematical model[J]. Endocr Rev, 1989, 10(3):232- 274. 被引量:1

共引文献45

同被引文献45

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部